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h i g h l i g h t s
 There is evidence for local use-dependent neuronal sleep modulation as a result of the lateralized
pathological motor profile.
 More bilateral motor symptoms and optimized treatment contribute to diminished sleep EEG
asymmetry.
 The association between symptomatic motor laterality and sleep neural asymmetry may provide tar-
geted therapeutic insights.
a b s t r a c t
Objective: Unilateral manifestation of motor dysfunction is a prominent hallmark of Parkinson’s disease
(PD). We investigated how the motor laterality of the disorder affects sleep neural asymmetry before and
after Deep Brain Stimulation (DBS).
Methods: Twenty-seven PD patients of the akinetic-rigid subtype were studied; 11 with right dominant
(RD) and 16 with left dominant (LD) motor symptoms. Neuronal sleep asymmetry was computed as the
difference of sleep slow-wave energy (SWE) between left and right hemispheres. We used linear mixed
models to assess the relationship between symptomatic profile and SWE asymmetry.
Results: LD PD patients exhibited frontal electroencephalographic (EEG) asymmetry and motor laterality
pre-DBS with increased SWE contralateral to their affected body side, which diminished post-DBS. The RD
group did not exhibit neither neural asymmetry nor motor laterality pre- and post-DBS. There was a sig-
nificant negative correlation between the motor laterality and sleep EEG asymmetry.
Conclusions: Our results suggest evidence for a local use-dependent modulation of SWE as a result of the
lateralized pathological motor profile. More bilateral motor symptoms and optimized treatment con-
tribute to diminished sleep EEG asymmetry.
Significance: These novel findings about the association between symptomatic motor laterality and sleep
neural asymmetry may provide targeted therapeutic insights.
 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Slow-wave activity (SWA; electroencephalographic (EEG)
power in the delta frequency range 1–4.5 Hz) is the hallmark brain
activity of deep sleep and reflects sleep depth and sleep need reg-
ulation (Achermann and Borbély, 2003). It is already established
that SWA can be regulated locally, in an activity-dependent man-
ner. SWA increases as a function of prior use and neuronal plastic-
ity (Esser et al., 2006; Huber et al., 2007; Tononi and Cirelli, 2014).
Specifically, increased synaptic activity due to motor learning can
selectively induce SWA in the previously activated cortical region
(Huber et al., 2004). Conversely, lack of activity after arm immobi-
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lization during the day leads to a local decrease of SWA over the
contralateral motor cortex (Huber et al., 2006). Furthermore,
slow-wave energy (SWE; cumulative SWA throughout a sleep epi-
sode) reflects total sleep need dissipation (Borbély, 1982;
Achermann and Borbély, 1990; Achermann et al., 1993; Werth
et al., 1996). SWE has been shown to be locally expressed as well
(Maric et al., 2017).
Parkinson’s disease (PD) is a progressive neurodegenerative
movement disorder owing primarily but not only to dopaminergic
denervation of the striatum leading to excessive abnormal syn-
chronization of neuronal activity in basal ganglia-cortical loops
(Hammond et al., 2007). This pathological synchronization is
thought to be inextricably linked to PD clinical phenotype charac-
terized by akinesia, muscle rigidity, postural instability and (rest-
ing) tremor. Treatments of PD include pharmacological
approaches, typically dopaminergic agents, and surgical therapies
as e.g. deep brain stimulation (DBS) of the subthalamic nucleus
(STN) or the globus pallidus internus (Armstrong and Okun, 2020).
A prominent distinctive pathological hallmark of PD is the
asymmetry of dopaminergic neurodegeneration at its onset,
accompanied by a characteristic unilateral manifestation of motor
dysfunction (Riederer et al., 2018). Asymmetry was shown to
become less prominent over the disease course (Nandhagopal
et al., 2009), while side of disease onset and progression of motor
impairment are not entirely independent from each other
(Baumann et al., 2014). Despite the impressive and poorly under-
stood asymmetrical nature of PD and the vast work on the subcor-
tical level, very few studies have investigated the potential neural
asymmetries of PD patients on a cortical level (Pollok et al., 2012;
Hall et al., 2014; Heinrichs-Graham et al., 2017). However, these
studies were focused on the investigation of motor-cortical oscilla-
tions (i.e., beta oscillations) in PD during wakefulness.
There is growing awareness of the bidirectional relationship
between sleep and PD. Schreiner and colleagues found an associa-
tion between higher SWE and slower motor progression (Schreiner
et al., 2019). Amato and colleagues showed that increased
actigraphy-based total sleep time was related to reduced motor
impairment (Amato et al., 2018). To our knowledge, no study to
date has investigated the association between symptomatic motor
laterality and sleep neural asymmetry. In this work, we hypothe-
sized a symptomatic use-dependent modulation of the sleep EEG
neural pattern in PD patients. We investigated how both neural
asymmetry and motor laterality of the disorder are affected before
DBS and under the optimized therapy of DBS, which should dimin-
ish neuronal asymmetry. We differentiate between PD patients
with left-sided onset and right-sided onset of motor symptoms.
2. Methods
This is a retrospective analysis of a subgroup of patients from an
observational controlled trial to examine effects of STN-DBS on
sleep–wake behavior in PD (for details see Baumann-Vogel et al.,
2017). Here we focused on PD patients of the akinetic-rigid sub-
type (the biggest subgroup of the trial) as tremor dominant sub-
types may modulate the sleep EEG neural pattern differently. The
study protocol was approved by the local ethics committee (KEK-
ZH-Nr.2013-0360), and written informed consent was given by
participating patients. The study has been carried out in accor-
dance with the Helsinki Declaration of 1975.
2.1. Patients
We analyzed data of 27 PD patients who suffer primarily from
akinesia and rigidity (AR subtype) and not from tremor and who
were treated with bilateral STN-DBS. The PD patients were
divided into two groups according to their motor symptom later-
ality profile; patients with right-sided onset of motor symptoms
belong to the right dominant (RD, n = 11, 2 females) group,
and patients with left-sided onset of motor symptoms were clas-
sified left dominant (LD, n = 16, 7 females). All patients were
right-handed.
2.2. Clinical assessment
Patients were examined twice, 3–6 months prior to surgery and
6 months after implantation of DBS electrodes and the bilateral
STN-DBS. More details on all assessments can be found in
Baumann-Vogel et al., 2017. Briefly, we examined motor outcomes
with part III of the Unified Parkinson’s Disease Rating Scale
(UPDRS). Before DBS, we assessed motor symptoms during an L-
dopa challenge test once in the off state and once at L-dopa peak
dose (Saranza and Lang, 2020). After STN-DBS, UPDRS assessments
were performed again in an ON state (on stimulation in combina-
tion with medication). To assess motor laterality in the PD patients,
we used lateral motor sub-scores of the UPDRS III. We computed a
motor laterality index (MLI) by calculating the ratio of the differ-
ence of the right (R) and left (L) motor sub-scores over their sum
((R  L)/(R + L)) (Kaasinen, 2016). Negative values of the laterality
score indicated dominant left side symptoms; positive scores indi-
cated dominant right side symptoms.
2.3. Whole-night PSG/EEG
Digital video polysomnography (PSG) recordings were per-
formed (Embla N7000, RemLogic v3.2) using six electrodes (2 fron-
tal, 2 central and 2 occipital) according to AASM standard criteria
(Berry et al., 2015). Sleep stage scoring (30-second epochs) was
done by sleep specialists very carefully and with additional stan-
dardized considerations as thoroughly described in Baumann-
Vogel et al. (2017).
2.4. EEG analysis
Pre-processing of the EEG signal included initially the re-
referencing of all electrodes to linked mastoids. The re-
referenced EEG signal was zero-phase high-pass filtered at 0.1 Hz
and low-pass filtered at 40 Hz. The filtered signal was decomposed
in the frequency domain using the Welch’s method and power
spectra were computed for each 30-second epoch based on averag-
ing of six 5-second windows using Hanning windowing. A semi-
automatic procedure was used for artefact-correction based on
power thresholds in the low (0.75–4.5 Hz) and high (20–30 Hz) fre-
quency ranges. SWA was computed as the EEG power between 1
and 4.5 Hz. SWEwas computed as the integral of the SWA through-
out the night, in that way both the amount of SWA as well as the
duration of consolidated non-rapid eye movement (NREM) sleep
(sleep stages N2 + N3) are taken into account for the assessment
of total sleep need dissipation. Global SWE was computed as the
average SWE across all electrodes. EEG asymmetry was computed
the same way as the MLI, namely, the ratio of the difference of SWE
between right and left electrodes over their sum ((R  L)/(R + L))
for the three cortical regions; frontal, central and occipital. A pos-
itive value of the laterality score indicated higher SWE over the
right brain side; a negative value indicated a higher SWE over
the left brain side. Analysis was performed in MATLAB (R2017b,
The Math-Works, Inc., Natick, Massachusetts, USA).
2.5. Statistical analysis
We used Shapiro-Wilk tests to test for normally distributed
data. In case of normally distributed data, we used Student’s t-
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tests for post hoc comparisons. When not normally distributed,
Wilcoxon’s rank-sum post hoc tests were used (we report descrip-
tive values of mean and standard error of the mean for normally
(i.e., mean ± sem) and median and interquartile range values (i.e.,
median ± iqr) for not normally distributed data). For correlation
analysis, we applied the non-parametric Spearman test. We used
linear models (LM) and linear mixed models (LMM) to describe
the data. We applied F-test statistics for the description of good-
ness of fit of the LM and Wald Chi-squared test statistics for the
description of goodness of fit for the LMM. For the LMM the patient
was treated as the random variable (varying in the intercept) and
we used the maximum likelihood method for the estimation of
the significant effects. We assessed the LM and LMM variable
selection using bidirectional stepwise regression according to the
Akaike Information Criterion (AIC) for model comparison. The step-
wise principle for model construction is an automatic procedure of
selecting the regression model that best describes the data. Ini-
tially, all the candidate predictive variables were included in the
description of the model and then a mathematical procedure was
used in order to estimate the final model that included the vari-
ables and/or their interactions that explained best the variation
of the outcome. Briefly, an initial model was defined only by the
intercept. At a next step, the predictor that best predicted the out-
come was selected according to highest correlation with the out-
come. If this predictor improved the ability of the model to
predict the outcome, then this predictor was retained in the model.
Each time a predictor was added, a removal test was made of the
least useful predictor. The procedure searched for a second predic-
tor by using semi-partial correlations with the outcome as a crite-
rion. At each step the resulting models were compared to each
other using the AIC which was computed as AIC = 2(log-likeli
hood) + 2k, where k was the number of model parameters includ-
ing the intercept and the log-likelihood was a measure of model fit.
The lower the AIC the better the fit of the model. The advantage of
this method is that it provides an objective way to estimate the LM
and LMM based on mathematical criteria. Analysis was performed
in R-3.5.1.
3. Results
3.1. Clinical and sleep characteristics of PD patients pre- and post-DBS
The two motor asymmetry groups (LD, RD) did not show any
differences regarding mean age (LD: 59.81 ± 2.56 years, RD: 62.8
2 ± 2.56 years, t(24.13) = 0.84, p = 0.41), disease duration (LD:
11.88 ± 0.98 years, RD: 12.45 ± 1.63 years, t(17.12) = 0.31,
p = 0.76) and disease stage-indicating Hoehn & Yahr values
(Hoehn and Yahr, 1967) (LD: 2 ± 0.5, RD: 2.5 ± 0. 5, W = 75.5,
p = 0.52).
Table 1 summarizes motor impairment, dopaminergic medica-
tion and PSG sleep stage findings in the two groups before and
after STN-DBS. Motor assessment in off stage showed similar high
UPDRS III scores in both groups (t(24.9) = 0.63, p = 0.53). Mean
score of UPDRS III at L-dopa dose peak improved in both groups
(LD: 28.3 ± 3.3, p < 0.001, RD: 20.6 ± 2.8, p < 0.001), however,
after a between-group comparison, we found that the RD group
was more severely affected compared to the LD group (Figure S1).
The mean UPDRS III values following DBS treatment did not show
any significant differences when comparing between the two con-
ditions for the two groups. The L-dopa equivalent dose was more
reduced following DBS treatment in the LD group (LD:
63.6%±6.11%, p < 0.001, RD: 56.23%±9.1%, p = 0.003). Calculation
of sleep parameters before and after DBS showed a decrease of
waking time after sleep onset (WASO) after DBS treatment for
the LD group (p = 0.048) but not for the RD group, while number
of awakenings did not differ. There was also an increase of post-
DBS total sleep time (TST) for the RD group (p = 0.042) but not
for the LD group. The rest of the sleep parameters did not show
any significant differences when comparing between the two con-
ditions for the two groups. These differences in WASO and TST for
the LD and RD group, respectively may be explained by analogous
changes in NREM and REM duration, which are not significant
probably due to high data variability. Nevertheless, when summed
up together they lead to the respective significant changes in
WASO and TST.
3.2. Global SWE: Pre-DBS comparison between LD and RD group
In a first step, the SWE averaged across all electrodes was com-
pared between the two groups. A simple linear model (Table S1)
was calculated to predict patients’ whole-night, global SWE based
on their age and group of motor asymmetry (LD or RD). A signifi-
cant regression equation was found (LM: F(3,22) = 6.97,
p = 0.002), with an R2 of 0.417. Motor asymmetry group
(b = 224, p = 0.043) and age (b = 3.75, p = 0.001) of the patient
were significant predictors of the resulting global SWE with the LD
group exhibiting a trend for higher SWE compared to the RD group
(t(21.22) = 1.84, p = 0.08, mean ± sem: LD: 75.72 ± 14.61 mV2, RD:
44.95 ± 8.17 mV2) (Fig. 1B). Because of the significant age effect,
the data was split by the median (62 years) into two age groups
for each of the asymmetry groups (LD and RD), however, no signif-
icant differences in SWE were found between the age groups (LD:
W = 45, p = 0.06, RD: t(6.06) = 0.12, p = 0.908.
3.3. Global SWE: Post-DBS changes in both LD and RD groups
In a next step, we investigated the changes in global SWE
after DBS. The stepwise LMM approach (Table S2) showed that
whole-night, global SWE was affected by DBS (v2(1) = 9.59,
p = 0.002, b = 20.4, se (standard error) = 6.94) and age
(v2(1) = 26.05, p < 0.001, b = 3.89, se = 0.72). There was also
a significant group by age interaction effect (v2(1) = 7.03,
p = 0.008, b = 3.26, se = 1.29) on the resulting SWE. The data
was split again by the median into two age groups and no differ-
ences in the SWE increase were found between the age groups in
neither asymmetry group (LD: t(11.96) = 0.29, p = 0.78, RD: t
(8) = 0.06, p = 0.96). The LD group showed a significant SWE
increase post-DBS (t(13) = 3.14, p = 0.008, 47.52 ± 15.15 %). Also,
the RD group exhibited a significant SWE increase after the treat-
ment (t(9) = 3.32, p = 0.009, 75.69 ± 22.77 %), with no difference
in mean global SWE increase between the two groups (t(16.5) =
1.03, p = 0.32) (Fig. 2, highlighted boxplots).
3.4. Local changes of SWE
In order to investigate local aspects of SWE in the PD patients, a
LMM (Table S3) was computed taking into account regional
changes in SWE (frontal (F), central (C), and occipital (O)). The step-
wise LMM approach revealed that DBS (v2(1) = 4.93, p = 0.026,
b = 17.69, se (standard error) = 6.56), age (v2(1) = 23.16,
p < 0.0001, b = 3.53, se = 0.51), cortical area (i.e., locality)
(v2(2) = 256.35, p < 0.0001, bFvsC = 83.84, se = 20.18, bFvsO =-
165.41, se = 20.18) and group of motor asymmetry
(v2(1) = 6.34, p = 0.012, b = 149.17, se = 53.17) were significant
predictors of changes in SWE. There was also a significant age by
locality interaction (v2(2) = 44.62, p < 0.001, bage:FvsC = 1.15,
se = 0.32, bage:FvsO = 2.08, se = 0.32), DBS by locality interaction
(v2(2) = 6.74, p = 0.034, bDBS:FvsC = 3.05, se = 6.13, bDBS:FvsO =-
14.57, se = 6.13) and group by age interaction (v2(1) = 6.67,
p = 0.01, b = 2.12, se = 0.85) revealed by the LMM. Statistical com-
parisons revealed that for the LD group SWE increase was signifi-
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cant in the frontal and central cortical sites, but not in the occipital
one (frontal: t(13) = 2.68, p = 0.02, central: t(13) = 2.4, p = 0.03,
occipital; t(12) = 1.19, p = 0.26), while the RD group showed signif-
icant increases in all cortical sites (frontal: t(9) = 3.22, p = 0.01, cen-
tral: t(8) = 3.22, p = 0.01, occipital: t(9) = 3.2, p = 0.01). Local SWE
changes are illustrated in (Fig. 2).
Table 1
Unified Parkinson’s Disease Rating Scale (UPDRS) part III assessments, dopaminergic medication equivalent dose and sleep parameters for left dominant and right dominant PD
groups pre- and post-DBS. Mean ± standard error of the mean. Abbreviations: LED, levodopa equivalent dosage; DBS, deep brain stimulation; OFF, off state; ON, on state; PSG,
polysomnography; TST, total sleep time; SL, sleep latency to N2; N1-3, non-rapid eye moment (NREM) sleep stages 1–3; REM, rapid eye movement sleep; WASO, wake after sleep
onset; nWASO, number of awakenings after sleep onset; SEFF, sleep efficiency. Unit abbreviations: mg, milligrams; min, minutes; #, number; %, percentage.
Left Dominant Right Dominant
Pre DBS Post DBS p-value Pre DBS Post DBS p-value
UPDRS III OFF 44.7 ± 3.8 – – 41.6 ± 2.9 – –
UPDRS III ON 16.4 ± 1.41 16.7 ± 1.6 0.9 21.1 ± 1.8 18.2 ± 1.5 0.17
LED total (mg) 1134.2 ± 91 432.3 ± 88.2 <0.001 1070.5 ± 171 420.4 ± 126.8 0.003
PSG sleep stages
TST (min) 319.6 ± 20.4 336.2 ± 21.3 0.313 255.2 ± 19.2 302 ± 26.7 0.042
SL (min) 20.5 ± 5.4 24.5 ± 5.9 0.518 45 ± 14.9 31.7 ± 7.8 1
NREM (min) 271.5 ± 17.1 279.5 ± 14.6 0.379 222.3 ± 18.2 264.5 ± 21.9 0.054
N1 (min) 68.3 ± 13.0 68.5 ± 7.3 0.877 62.4 ± 11.0 74 ± 12.4 0.32
N2 (min) 158.8 ± 11.0 151.4 ± 11.2 0.571 123.6 ± 14.1 140.9 ± 15.3 0.32
N3 (min) 44.4 ± 9.4 59.5 ± 9.7 0.155 36.3 ± 10.5 49.6 ± 10.9 0.147
N2 + N3 (min) 203.2 ± 16.3 210.9 ± 15.6 0.68 159.9 ± 16.1 190.6 ± 21 0.28
REM (min) 48.1 ± 6.7 56.8 ± 8.6 0.535 32.9 ± 10.1 37.5 ± 8.2 0.557
WASO (min) 104.4 ± 15.4 81.2 ± 15.2 0.048 128.9 ± 10.6 101.9 ± 25.6 0.122
nWASO (#) 50.6 ± 9 45.3 ± 6.3 0.979 46.2 ± 6.5 40.4 ± 4.1 0.288
SEFF (%) 72.3 ± 4.4 76.4 ± 4.3 0.088 59.8 ± 4.4 70.1 ± 6.4 0.083
Fig. 1. (A) Individual global slow-wave energy (SWE) traces for both groups (LD, left dominant; RD, right dominant) throughout the night before deep brain stimulation (pre-
DBS). Accumulated slow-wave activity (SWA) over time (all non-rapid eye movement (NREM) stages N2 and N3 episodes). (B) Boxplot showing total sleep need dissipation
for the LD and the RD group before DBS treatment.
Fig. 2. Increase in slow-wave energy (DSWE) after deep brain stimulation (DBS) treatment for both asymmetry groups (LD, left dominant; RD, right dominant) on the global
and on the local (frontal, central and occipital) level. Asterisks denote statistical significance of SWE increases (global and local changes, p < 0.05).
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3.5. Left-right sleep EEG asymmetry
Next, we computed the left–right asymmetry of SWE for the
three recorded cortical regions; frontal, central and occipital. No
asymmetry was evident for the central and occipital regions for
the two groups in neither of the two conditions (e.g., pre- and
post-DBS) (Figure S2). The stepwise LMM approach (Table S4)
showed a significant effect of DBS treatment (v2(1) = 6.48,
p = 0.01, b = 0.031, se (standard error) = 0.013) on the frontal
SWE asymmetry (i.e., frontal SWE asymmetry diminishes after
DBS) and a trend in the group effect (v2(1) = 3.42, p = 0.064,
b = 0.032, se = 0.02) (i.e., trend for less frontal SWE asymmetry
for the RD group). No age effect was evident after stepwise regres-
sion. Before treatment, the LD group exhibited frontal SWE asym-
metry (t(14) = 2.33, p = 0.035, 0.031 ± 0.013) with the left cortical
side showing less SWE than the right cortical side, while the RD
group did not show any asymmetrical SWE (t(10) = 0.88,
p = 0.4, 0.016 ± 0.018). A direct comparison of the asymmetry
between the two groups revealed that they differed in their asym-
metrical sleep EEG activity (t(19.66) = 2.1, p = 0.049) (Fig. 3A). After
DBS treatment, both the LD group and the RD group did not exhibit
any asymmetry in SWE (LD: t(14) = 0.83, p = 0.42,0.012 ± 0.014,
RD: t(9) = 1.67, p = 0.13, 0.029 ± 0.017) and also no difference
between their mean SWE asymmetry (t(19.12) = 0.79, p = 0.44)
(Fig. 3A). In-group comparisons showed a significant difference
between pre- and post-DBS SWE asymmetry for the LD group (t
(13) = 3.15, p = 0.008), but not for the RD group (t(9) = 0.5,
p = 0.63) (Fig. 3A).
3.6. Clinical outcome linked to frontal sleep EEG asymmetry
To test whether the SWE asymmetry in the frontal electrodes
was associated with the clinical outcome after DBS, we applied
the stepwise LMM approach on the motor laterality index (MLI)
(Table S5) which revealed that group of asymmetry
(v2(1) = 10.96, p = 0.001, b = 0.47, se (standard error) = 0.13)
was a significant predictor for the MLI (i.e., less motor laterality
for the RD group), while there was a trend in the DBS effect
(v2(1) = 3.39, p = 0.07, b = 0.3, se = 0.12) and the group by DBS
interaction (v2(1) = 3.53, p = 0.06, b = 0.33, se = 0.19). Before
DBS treatment the LD group exhibited significant motor laterality
(t(15) = 4.85, p < 0.001, 0.4 ± 0.08) with the patients showing more
severe motor symptoms on their left body side while the RD group
did not show such motor symptom laterality (t(10) = 0.32,
p = 0.75, 0.02 ± 0.05). The two groups differed significantly in
their pre-DBS MLI (t(22.44) = 4.4, p < 0.001) (Fig. 3B). On DBS treat-
ment, both groups had diminished motor laterality (LD: t
(15) = 1.17, p = 0.26, 0.11 ± 0.1, RD: t(10) = 0.08, p = 0.94,
0.01 ± 0.1) with no differences between the groups (t
(22.88) = 0.72, p = 0.48) (Fig. 3B). In-group comparisons showed
a significant difference between pre- and post-DBS MLI for the
LD group (t(15) = 2.44, p = 0.028), but not for the RD group (t(10
) = 0.2, p = 0.84) (Fig. 3B). Moreover, a negative correlation was
found between MLI and frontal SWE asymmetry before the DBS
treatment when the two groups are pooled (n = 26, rs = 0.5,
p = 0.011), however, there was no such correlation between later-
ality in motor symptoms and SWE asymmetry post-DBS (n = 25,
rs = 0.17, p = 0.43) (Fig. 3C).
4. Discussion
The overall aim of this work was to identify asymmetries in the
sleep EEG in akinetic-rigid PD patients before DBS and under opti-
mized treatment after DBS surgery. The two prominent PD symp-
tomatic profiles in respect to left and right motor symptom
dominance were analyzed separately. Before focusing on the asym-
metry, we carefully assessed the background differences in SWE
between the groups and found that pre-DBS the RD group exhib-
ited a trend for lower SWE compared to the LD group. Taking into
account the higher motor severity of the RD group pre-DBS, this
observation is in accordance with the results of Baumann et al.
(2014) showing an association between right–side akinetic-rigid
patients and faster disease progression (Baumann et al., 2014) in
combination with the results of Schreiner et al. (2019) who showed
that lower SWE also relates to faster disease progression (Schreiner
et al., 2019). Succeeding DBS treatment, both groups showed an
increase in global SWE, as it has been shown by Baumann-Vogel
and colleagues before (Baumann-Vogel et al., 2017). Altered sleep
architecture (Table 1) following DBS treatment could be a possible
confounder for our observation. SWE increase from the two groups
seem to have different profiles. LD PD patients deepened NREM
sleep, whereas RD PD patients consolidate sleep by increasing total
sleep time resulting in more time to accumulate SWE. Our results
suggest different neurophysiological responses to PD depending on
the grade of motor severity. Here the RD PD patients had higher
pre-DBS UPDRS III scores.
Following our hypothesis for a local use-dependent modula-
tion of SWE reflecting the lateralized motor pathology of the
patients, we investigated the sleep EEG asymmetry in the three
cortical regions; frontal, central and occipital. Indeed, neural
asymmetry was only evident locally in the frontal cortex. A cor-
relational analysis revealed a correlation between the motor lat-
erality index and sleep EEG asymmetry, namely the more
prominent the motor laterality the more evident the sleep EEG
asymmetry. LD PD patients exhibited significant EEG asymmetry
pre-DBS with the more affected side (i.e., right frontal cortex)
showing higher SWE compared to the less affected side (i.e., left
frontal cortex). They also showed significant motor lateralization
with more severe motor symptoms on their left body side. This
observation could be evidence for a local use-dependent modula-
tion of SWE as a result of the lateralized pathological motor pro-
file of akinetic-rigid PD patients. Previous studies (in healthy
subjects) have shown that excessive synaptic activity due to
motor learning locally increases SWA activity in the respective
cortical region (Tononi and Cirelli, 2014) and, conversely, reduced
synaptic activity due to immobilization causes local SWA
decrease (Huber et al., 2004). Nevertheless, it is worth mention-
ing that rigidity and/or bradykinesia in akinetic-rigid PD patients
does not simulate immobility in healthy population, but is rather
expressed with difficulties in movement initiation (hence more
‘‘training” or force demand on the affected side) due to its neu-
rodegenerative origin. In contrast to the LD group, the RD group
did not exhibit neither neural asymmetry nor motor laterality
pre-DBS. A possible reason why we observed no asymmetry in
akinetic-rigid patients with right-sided onset of motor signs
could be that this group typically shows a more rapid progression
of motor symptoms compared to LD patients (Baumann et al.,
2014), hence, symptoms become bilateral. Another possible
explanation for this observation could be framed under the con-
cept of impaired control of habitual behavior (e.g., spontaneous,
over-trained motor control) and a shift to goal-directed behavior
(e.g., novel, computationally more intensive motor control) in the
Parkinsonian state (Redgrave et al., 2010; Bichsel et al., 2018).
Moreover, in our cohort all the PD patients in both groups were
right-handed. Hence, it would require greater and more intensive
effort for the RD patients to perform their habitual right-hand
movements compared to the LD patients. Interestingly, it has also
been shown that there is a unique correlation between PD symp-
tomatic profile and asymmetry of beta activity (i.e., motor-
cortical oscillations) in the wake state during right-hand move-
ment, such that LD PD patients show more left-lateralized (i.e.,
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contralateral to movement) beta response. Conversely, RD PD
patients exhibit more right-lateralized (i.e., ipsilateral to move-
ment) beta response (Heinrichs-Graham et al., 2017). This ‘‘redi-
rection” of activity to the healthy hemisphere during right-hand
movement execution in RD patients in combination with the
more demanding and intensive neuronal plastic processes under-
lying goal-directed movements might increase the homeostatic
drive resulting in higher SWE and thus masking the SWE asym-
metry during sleep. After DBS treatment neural asymmetry and
motor laterality indices diminished for both groups, hence, no
correlation between these two was evident anymore. The effec-
tive DBS treatment and clear reduction of the unilateral manifes-
tation of motor dysfunction may account for the diminished
neural and motor symptom asymmetry. On the other side, EEG
asymmetry effects could have been more prominent when
patients would have been in the ‘‘off-state” since the dopaminer-
gic treatment may mask motor laterality and EEG asymmetry
(Table 1). Moreover, dopaminergic neurotransmission in striatum,
the target of levodopa-based therapy in PD, plays also an impor-
tant role in healthy brain functioning including the circadian
rhythms and sleep (Videnovic and Golombek, 2017). Whether
asymmetry of dopaminergic neurotransmission may affect the
sleep-wake circuit directly leading to sleep EEG asymmetry
and/or only indirectly through their motor symptoms in a use-
dependent manner remains open. As dopamine primes the brain
for enhanced vigilance one could speculate that lateralized
dopaminergic dysregulation might result in direct sleep EEG
asymmetry in PD.
The small sample size and the few EEG channels are limitations
and a larger study, and a higher EEG resolution would be needed to
confirm these results.
Nevertheless, we were still able to show a relationship between
motor laterality and SWE asymmetry as well as differences
between the two groups and optimized treatment. Thus, the
importance of taking patient symptom heterogeneity into consid-
eration towards more personalized treatment is highlighted.
5. Conclusion
Our study was the first to assess any relationship between
symptom laterality and sleep EEG asymmetry in PD patients. We
were able to show a relationship between motor laterality and
SWE asymmetry, differences between the two groups according
to their motor laterality and differences after optimized treatment.
Further experimental sleep modulation studies need to be per-
formed in order to elucidate the causal relationship between sleep
and motor symptoms in PD.
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